|Articles|May 1, 2017
- Pharmaceutical Executive-05-01-2017
- Volume 37
- Issue 5
Pharmaceutical Executive, May 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Brand of the Year: A Retrospectivealmost 9 years ago
Portfolio Management Health Checkalmost 9 years ago
Launch for Long-Term Successalmost 9 years ago
Merck’s Latest Shot Against Shinglesalmost 9 years ago
Measuring the Value of Prescription Drugsalmost 9 years ago
Life Sciences' Shifting Sands: 5 Trends that Threaten the Status Quoalmost 9 years ago
New Life in European Drug Pricing Spatalmost 9 years ago
Country Report: SwitzerlandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
What Governance Resets Should Pharma Companies Take in Response to AI?
3
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
4
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
5